We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Futura Medical Plc | LSE:FUM | London | Ordinary Share | GB0033278473 | ORD 0.2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
2.90 | 7.88% | 39.70 | 39.35 | 39.70 | 39.70 | 37.80 | 37.80 | 649,629 | 14:03:10 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -5.85M | -0.0194 | -20.46 | 119.38M |
Date | Subject | Author | Discuss |
---|---|---|---|
08/4/2023 12:39 | Funny how LiarBO attempts to change the subject when he's been pinned down to yet another lie. | petroc | |
08/4/2023 12:14 | Oh Joe! The Irony!!! Or should I say ironia! Which is the Finnish word for those like Joe - ironia - it explains the constant sense of irony everytime Joe posts now in the multi-ID ramper camp!!! ROFLMAO JoeStalin - 22 Jan 2018 - 11:16:41 - 3640 of 17304 Only a clown thinks selling a few packs at all makes for a business. JoeStalin - 30 Sep 2019 - 10:07:37 - 5937 of 10774 FUTURA a winner for 2015 - says it all! JoeStalin - 18 Jul 2018 - 09:00:46 - 4354 of 10775 'jam tomorrow' is a very easy promise to make. JoeStalin - 22 Jun 2018 - 14:12:24 - 4288 of 10775 What's another year after all? At FUM, time is measured in decades. JoeStalin - 25 Apr 2018 - 16:07:34 - 4147 of 10775 There seems to be an unlimited number of ways of saying "Jam tomorrow". JoeStalin - 21 Mar 2018 - 13:50:44 - 3985 of 10775 A lifestyle company, but not for the shareholders | lbo | |
08/4/2023 12:13 | Come on Petroc at least attempt to answer the relevant questions! Stop with the feeble deflection. So where is the enforceable patent you said ‘FACTS’ coming soon? petroc - 21 Jan 2022 - 18:03:42 - 10541 of 10710 What is not to love Eroxon /MED3000 - HERE ARE THE FACTS - Patent application in progress using patent lawyers - COMING SOON Yet over a year later and no patent! Another one of Petrocs lies exposed! Because its all based on ‘bias and fraud’ by a group of connected multi-ID rampers around basically trying to give more credence by false and misleading posts on bulletin boards and social media to what is effectively an arousal gel with no evidence form any direct efficacy blinded comparison study to claim otherwise and with no enforceable patent on something that already exists in the market and is well described in the literature! The only thing burying the rampers is they can never provide any real non deficient evidence to substantiate any of their false and misleading claims. The Company has conducted initial literature and in vitro based research that has shown the cooling from the evaporation of these specific combinations of solvents Voltarol Emugel vehicle is made of the same ˜evaporate cooling’ ingredients as in Eroxon carbomer, isopropyl alcohol, propylene glycol, water ‘TPR100 gave similar results to the gold standard, Voltarol 2% gel’ The cooling effect of a topically applied product can be evaluated using a validated handheld thermal imaging system. When the gel matrix is destroyed after application to the skin, the bound water and alcohol evaporates and a measurable cooling-effect results. Consumer satisfaction with a topical product is based on subjective criteria such as how the product feels and how it is perceived on the skin. Therefore, appropriate questionnaires are of major importance for cosmetic products to assess the subjective perception not only of soothing and cooling effects but also of moisturizing properties and fragrance. A key element of Futura Medicals strategy is to reduce development risk through using well characterised existing agents that are reformulated with its proprietary DermaSys technology to create new products. This means intellectual property protection is limited to use patents for the individual products and umbrella patents for the technology. There is a risk that some claims will either be challenged in future (eg on the grounds of non-obviousness or existence of prior art) and/or that another technology may be employed to achieve a similar effect | lbo | |
08/4/2023 12:11 | I just discovered that there is a Finnish word for those like LBO - it is runkkari - it explains his constant sense of disappointment. | joestalin | |
08/4/2023 12:05 | Its also ironic that the 'experts' Petroc (the only proven multi-ID) referenced openly said in the webinar with some men that 'Their ED, if it is such, can actually be more a loss of confidence that they will be able to perform with their partner. Each of the Profs. felt that Eroxon was a safe alternative to stimulate the younger person's confidence'So thats a very eloquent admission of psychological ED or as the experts said 'Their ED, if it such' and the use of a Placebo gel to 'stimulate confidence' . So who is telling lies on what Eroxon actually is stimulating? The experts or the rampers!?So its all based then on the proven multi-ID rampers marketing a confidence' trick based on men overpaying for an arousal gel as a fake' treatment. Or as the FTC said a placebo 'form of fraud' and a swindle' No wonder no sign of any upfront payments from Cooper or why Co-High dont even seem to want to outlay any costs to progress in China any further! It seems even the Chinese understand the English for placebo 'form of fraud' better then Petroc and all his multiple personalities!!! LOLhttps://www.ftc.g | lbo | |
08/4/2023 12:02 | 'Now the multi-ID ramper just keeps posting more names from more unknown names claiming I am everyone! Next he will be claiming I am him too! ROFLMAO' Once again, LiarBO, but try to make it intelligible this time! | petroc |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions